home / stock / ntla / ntla articles


NTLA Articles, Intellia Therapeutics Inc. - From 02/06/24

Stock Information

Company Name: Intellia Therapeutics Inc.
Stock Symbol: NTLA
Market: NASDAQ
Website: intelliatx.com

Menu

NTLA NTLA Quote NTLA Short NTLA News NTLA Articles NTLA Message Board
Get NTLA Alerts

News, Short Squeeze, Breakout and More Instantly...

Not Shy Of Buying The Dip, Cathie Wood's Ark Mops Up Over $11M Worth Of Shares In Tesla — Sells Nvidia Stock | Benzinga

Cathie Wood-led Ark Invest bolstered its portfolio by purchasing over $11 million worth of Tesla Inc (NASDAQ:TSLA) shares, marking a significant vo...

Cathie Wood's Ark Invest Snatches Up $4.7M More In Tesla Shares, Invests Equally In This Rocket Company | Benzinga

In a notable move on Thursday, Cathie Wood‘s Ark Invest acquired a substantial number of Tesla Inc (NASDAQ:TSLA) shares, valued at approximat...

Intellia Therapeutics Highlights its Three-Year Strategic Priorities and Anticipated 2024 Key Milestones | Benzinga

Core priorities through 2026 include completion of Phase 3 study and BLA submission for NTLA-2002, completion of patient enrollment in the pivota...

Why ReNew Energy Global Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session | Benzinga

Shares of ReNew Energy Global Plc (NASDAQ: RNW) gained during Monday’s session following strong quarterly sales. ReNew Energy Global posted q...

Why Intellia Therapeutics Stock Is Surging Tuesday | Benzinga

Intellia Therapeutics Inc (NYSE: NTLA) shares are trading higher Tuesday after the company announced it received European Union orphan dr...

Cathie Wood Continues On Roku Shares Selling Spree After Company's Q3 Revenue Jump — Ark Sells $21.1M Of Stock | Benzinga

On Monday, Cathie Wood’s Ark Invest made a series of strategic trades, with the sale of Roku shares standing out as the most significant tran...

Intellia Therapeutics to Present Updated Data from Ongoing Phase 1 Study of NTLA-2001 for the Treatment of Transthyretin (ATTR) Amyloidosis and Hold Conference Call to Discuss Third Quarter 2023 Earnings in November | Benzinga

New interim NTLA-2001 clinical data to be presented at the 4th International ATTR Amyloidosis Meeting on November 2; data to include safety and b...

Cathie Wood's Ark Offloads $6.3M In Tesla Shares Amid EV Maker's Q3 Earnings Disappointment | Benzinga

On Wednesday, Cathie Wood-led Ark Invest made headlines by selling nearly $6.3 million worth of Tesla Inc (NASDAQ:TSLA) shares, a move that comes a...

Cathie Wood's Ark Invest Sells $9.8M Worth Of Tesla Shares — Second Day Of Selling EV Giant In A Row | Benzinga

On Wednesday, Cathie Wood-led Ark Invest continued its trend of selling shares of Tesla Inc (NASDAQ:TSLA), disposing of nearly $10M worth. This mar...

Cathie Wood's Ark Invest Keeps On Cutting Tesla Holdings, Sells More Than $8M Worth Of EV Maker's Shares | Benzinga

On Tuesday, Cathie Wood-led Ark Invest made a notable move by selling over $8 million worth of Tesla Inc (NASDAQ:TSLA) shares. This significant tra...

Previous 10 Next 10